Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,628 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06783244 | Low Versus Standard Intraabdominal Pressure in Robot-assisted Colorectal Cancer Surgery(LIPS) | recruiting | N/A | 200 | Victoria RosbergOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06869577 | A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma(SUGRI) | not yet recruiting | N/A | 24 | Rigshospitalet, DenmarkOTHER | 1 | Apr 29, 2025 |
| clinicaltrials |
| NCT06343987 | The FEMA Study: Feasibility of Exercise in Patients With Metastatic Breast Cancer and Adiposity | completed | N/A | 21 | Aarhus University HospitalOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT00472459 | Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer | completed | Phase 3 | 82 | Galderma R&DINDUSTRY | 5 | Apr 18, 2025 | clinicaltrials |
| NCT04209465 | A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.(MasterKey-01) | terminated | Phase 1 | 91 | Black Diamond Therapeutics, Inc.INDUSTRY | 4 | Apr 17, 2025 | clinicaltrials |
| NCT06537804 | Project Lung Cancer Screening in Southern Denmark(PLUS) | active not recruiting | N/A | 1,332 | Odense University HospitalOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06480110 | Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer | recruiting | Phase 1 / Phase 2 | 30 | Rigshospitalet, DenmarkOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT05378139 | Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization | unknown | — | 3,095 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT04775485 | A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors(FIREFLY-1) | recruiting | Phase 2 | 141 | Day One Biopharmaceuticals, Inc.INDUSTRY | 11 | Apr 10, 2025 | clinicaltrials |
| NCT04637464 | Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer | completed | N/A | 93 | Kjeld SchmiegelowOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT05406635 | Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer(HER2BIC) | recruiting | N/A | 220 | Odense University HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT03353831 | Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer | completed | Phase 3 | 574 | AGO Research GmbHINDUSTRY | 12 | Apr 6, 2025 | clinicaltrials |
| NCT04066153 | Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions | completed | — | 43 | Rigshospitalet, DenmarkOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT04188652 | Diagnosing Ovarian Cysts - the DOC Study | completed | — | 1,123 | Rigshospitalet, DenmarkOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT05608746 | Prehabilitation in Prostate Cancer Patients, TelePrehabTrial | active not recruiting | N/A | 40 | University of AarhusOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT05710809 | The SaVe Project-Sarcopenia and Vertigo in Aging Patients With Colorectal Cancer(SaVe) | recruiting | N/A | 150 | Rigshospitalet, DenmarkOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT05746754 | Proton Cranio-spinal Irradiation for Leptomeningeal Metastasis(CSI ProLong) | recruiting | N/A | 50 | University of AarhusOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT06361862 | Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?(WARD-OT) | completed | N/A | 700 | Rigshospitalet, DenmarkOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT02017717 | A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients(CheckMate 143) | completed | Phase 3 | 529 | Bristol-Myers SquibbINDUSTRY | 12 | Apr 4, 2025 | clinicaltrials |
| NCT04236414 | Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours | completed | Phase 1 | 16 | AstraZenecaINDUSTRY | 6 | Apr 4, 2025 | clinicaltrials |
| NCT03749707 | HPV in Sentinel Lymph Nodes of Cervical Cancer Patients | completed | N/A | 127 | University of AarhusOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT03749720 | HPV in Blood Samples From Cervical Cancer Patients. | completed | N/A | 141 | University of AarhusOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT05284877 | The Organ Transplant Recipient HPV and Skin Cancer Study | recruiting | — | 1,500 | Merete HaedersdalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT02170090 | Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer(ACTICCA-1) | active not recruiting | Phase 3 | 789 | Universitätsklinikum Hamburg-EppendorfOTHER | 8 | Mar 30, 2025 | clinicaltrials |
| NCT03871829 | Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab | terminated | Phase 2 | 88 | Janssen Research & Development, LLCINDUSTRY | 13 | Mar 30, 2025 | clinicaltrials |
| NCT02322905 | Cancer Caregiver Burden: Targeting Emotion Regulation in a Trial(ERT-ICs) | completed | N/A | 80 | University of AarhusOTHER | 1 | Mar 24, 2025 | clinicaltrials |
| NCT00490139 | ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D(ALTTO) | completed | Phase 3 | 8,381 | Novartis PharmaceuticalsINDUSTRY | 44 | Mar 21, 2025 | clinicaltrials |
| NCT04939844 | REST - Replacing Steroids in the Transplant Ineligble(REST) | completed | Phase 2 | 51 | Oslo University HospitalOTHER | 2 | Mar 20, 2025 | clinicaltrials |
| NCT03235544 | A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor((CITADEL-205)) | completed | Phase 2 | 162 | Incyte CorporationINDUSTRY | 11 | Mar 18, 2025 | clinicaltrials |
| NCT04717700 | Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients(SABLe) | active not recruiting | Phase 2 | 50 | Ida Bruun KristensenOTHER | 3 | Mar 18, 2025 | clinicaltrials |
| NCT05899465 | Perioperative Treatment With Tranexamic Acid in Melanoma(PRIME) | recruiting | Phase 3 | 1,204 | University of AarhusOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT02492711 | Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer(SOPHIA) | completed | Phase 3 | 624 | MacroGenicsINDUSTRY | 18 | Mar 17, 2025 | clinicaltrials |
| NCT04263467 | High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM)(HIAIM) | active not recruiting | N/A | 54 | Herlev HospitalOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT03126019 | A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma(CITADEL-203) | completed | Phase 2 | 126 | Incyte CorporationINDUSTRY | 13 | Mar 14, 2025 | clinicaltrials |
| NCT06302361 | Lymphovenous Anastomosis for Breast Cancer Lymphedema | active not recruiting | N/A | 47 | Odense University HospitalOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT06845267 | Chrono-behavioral Therapy for Chronic Fatigue in Cancer(ChronoBT) | not yet recruiting | N/A | 200 | Aarhus University HospitalOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT04247165 | Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.(LAPTOP) | completed | Phase 1 / Phase 2 | 55 | Herlev HospitalOTHER | 1 | Mar 12, 2025 | clinicaltrials |
| NCT02278887 | Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma(TIL) | completed | Phase 3 | 168 | The Netherlands Cancer InstituteOTHER | 2 | Mar 10, 2025 | clinicaltrials |
| NCT05619744 | A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas | completed | Phase 1 | 41 | Hoffmann-La RocheINDUSTRY | 5 | Mar 10, 2025 | clinicaltrials |
| NCT01958021 | Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer(MONALEESA-2) | completed | Phase 3 | 668 | Novartis PharmaceuticalsINDUSTRY | 29 | Mar 7, 2025 | clinicaltrials |
| NCT05740137 | Adenoma Detection Rate in Artificial Intelligence-assisted Colonoscopy | completed | N/A | 795 | Ismail GögenurOTHER | 1 | Mar 6, 2025 | clinicaltrials |
| NCT00353496 | Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours(CLARINET) | completed | Phase 3 | 264 | IpsenINDUSTRY | 15 | Mar 5, 2025 | clinicaltrials |
| NCT04963270 | A Study To Evaluate Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Generalized Myasthenia Gravis | terminated | Phase 3 | 188 | Hoffmann-La RocheINDUSTRY | 17 | Feb 28, 2025 | clinicaltrials |
| NCT06848738 | Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound(IMPROVED) | enrolling by invitation | N/A | 362 | Zealand University HospitalOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT02377999 | Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts | completed | Phase 2 | 40 | LEO PharmaINDUSTRY | 1 | Feb 24, 2025 | clinicaltrials |
| NCT03047928 | Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma | completed | Phase 1 / Phase 2 | 48 | Inge Marie SvaneOTHER | 1 | Feb 20, 2025 | clinicaltrials |
| NCT05243342 | A Study to Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination With Daratumumab in Participants With Relapsed/Refractory Multiple Myeloma | completed | Phase 1 | 18 | Genentech, Inc.INDUSTRY | 4 | Feb 17, 2025 | clinicaltrials |
| NCT06259279 | High Impact Training to Patients with Prostate Cancer and Bone Metastases(HIP) | recruiting | N/A | 102 | Copenhagen University Hospital at HerlevOTHER | 1 | Feb 13, 2025 | clinicaltrials |
| NCT04903899 | 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma(LuDO-N) | recruiting | Phase 2 | 24 | Jakob StenmanOTHER | 5 | Feb 11, 2025 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials